Regarded as a damaging reaction, innate immune response can either improve or worsen brain outcome after injury. Hence, inflammatory molecules might modulate cell susceptibility or healing events. The remyelination that follows brain lesions is dependent on the recruitment of oligodendrocyte progenitor cells (OPCs) and expression of genes controlling differentiation and myelin production, such as Olig1 and Olig2 bHLH transcription factors. We aimed to determine how innate immunity affects these processes. Here we report that lipopolysaccharide (LPS) infusion triggered OPC reactivity. Acute inflammation changed the distribution of Olig1-and Olig2-expressing cells following chemical demyelination, enhanced reappearance of transcription signals linked to remyelination and rapidly cleared myelin debris. Although cells expressing Olig1, Olig2, and proteolipid protein were attracted to demyelinated sites in the course of chronic inflammation, myelin loss was not associated with the effects of inflammation on OPC reactivity. In addition, the beneficial properties of brain immunity are broadened to an aggressive model of injury, wherein LPS through Toll-like receptor 4 (TLR4) reduced surfactant-mediated damage while anti-inflammatory treatment enlarged the lesion. In conclusion, TLR4 activation in microglia is a powerful mechanism for improving repair at the remyelination level and protecting the cerebral tissue in presence of agents with strong cytolytic properties.
present in cell wall component from Gram-negative bacteria (7, 8) . The binding of LPS to its cognate TLR4 triggers NF-κB transduction pathway, which leads to the transcriptional activation of proinflammatory cytokines, chemokines, and other genes essential for pathogen elimination (9, 10) . Although the immune response is critical for brain protection, microglial cells and proinflammatory signaling have become hallmarks of neurodegenerative processes, and the inhibition of different cytokines and chemokines was found to have neuroprotective properties (1, 11) . Nevertheless, microglia reactivity removes cell debris and provides trophic support to neuronal elements (12, 13) . It is, therefore, critical to better understand how microglia and proinflammatory signaling modulate the molecular mechanisms involved in brain repair and cellular resistance to insults for the development of more adequate therapeutic strategies.
Remyelination offers an appropriate model for studying the impact of the brain immune response on tissue recovery. This healing process follows the loss of myelin sheaths, a feature of multiple sclerosis (MS) and other demyelinating diseases. In MS patients, roughly two-and-a-half million people worldwide, remyelination may become inefficient with disease progression and accumulation of lesions results in progressive neurological demise (14) (15) (16) (17) . Generation of new oligodendrocytes, the myelinating cells in the CNS, is required for repairing demyelinated axons (16, (18) (19) (20) (21) . Olig2 basic helix-loop-helix (bHLH) transcription factor is necessary for oligodendrocyte lineage specification during development (22-25). According to gain-offunction analysis, a role for the close homologue Olig1 was suggested in the development of oligodendrocyte progenitor cells (OPCs) (26). Furthermore, Olig1 and Olig2 play a role in the association of neurons and oligodendrocytes during development (27, 28). Studies involving Olig1 null mice revealed that this transcription factor does not affect the formation of OPCs, but it is critical for remyelination and transcription of myelin-specific genes (29, 30).
Because inflammation clearly takes place in MS lesions and during acute injuries (15, 31), we assessed whether stimulation of CNS immune system affects the mobilization of cells expressing Olig1, Olig2, and genes encoding components of myelin sheath following acute and more chronic models of demyelination. To evaluate general aspects of the effect of inflammation on aggressive brain insults, we also verified the impact of TLR4 activation and NF-κB signaling on the lesion induced by surfactant-mediated cytolysis.
MATERIALS AND METHODS

Animal experimentation
Adult male C3H/HeN, C57Bl/6, CD1 mice (body weight, 25-29 g; Charles River Canada, St. Constant, Québec, Canada), C3H/HeJ mice (Jax Mice; Jackson Laboratory, Bar Harbor, ME), or Sprague Dawley rats (body weight, 250 g; Charles River Canada) were acclimated to standard laboratory conditions (14/10 h light/dark cycle; lights on at 6:00 A.M. and off at 8:00 P.M.) with ad libitum access to rodent chow and water. Animal breeding and experiments were conducted according to Canadian Council on Animal Care guidelines, as administered by the Laval University Animal Care Committee. Efforts were made for minimizing animal number utilization; 3 to 5 animals were used in each experimental group.
Inflammatory treatment and acute demyelination
C57Bl/6 mice receiving intraparenchymal injections were anesthetized with isoflurane (Baxter Corporation, Toronto, ON, Canada) and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA). The corpus callosum was reached using a small cannula (28 gauge; Plastic One, Roanoke, VA) at the coordinates -1.0 mm anteroposterior, -1.0 mm lateral, and -2.0 mm dorsoventral according to a mouse brain atlas (32). The animals received an infusion of either sterile pyrogen-free saline (1 μl), LPS (2.5 μg; from Eschericia coli; serotype O55:B5; Sigma L2880), a mixture of LPS (2.5 μg) and ethidium bromide (EtBr, 0.1% final concentration) solution, or EtBr over 2 min by means of a microinjection pump (model A-99; Razel Scientific Instruments, Stanford, CT). These animals were killed 2 days (d) after the injection. Another group was administered with a lower dose (LPS, 1 μg; EtBr, 0.05%) and was killed 5 days postlesion. Animals were deeply anesthetized via an intraperitoneal injection of a mixture of ketamine hydrochloride and xylazine and then rapidly perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde in 0.1 M borax buffer, pH 9.5, at 4°C. Brains were removed rapidly from the skulls, postfixed for 2-4 d, and then placed in a solution containing 10% sucrose diluted in 4% paraformaldehyde-borax buffer overnight at 4°C. The frozen brains were mounted on a microtome (Reichert-Jung; Cambridge Instruments Company, Deerfield, IL) and cut into 25 μm coronal sections. The slices were collected in cold cryoprotectant solution (0.05 M sodium phosphate buffer, pH 7.3; 30% ethylene glycol; and 20% glycerol) and stored at -20°C.
Chronic intrastriatal infusions
A chronic indwelling cannula was implanted to deliver the intrastriatal treatments in rats as described previously (33). Briefly, for the guide cannula (22 gauge; C313G; Plastic One) coordinates from bregma were 0.0 mm anteroposterior, -3.0 mm lateral, and -2.8 mm dorsoventral. The guide cannula was secured with screws and cranioplastic cement. After the recovery period, a mini-osmotic pump (Alzet model 2004; Durect Corporation, Cupertino, CA), connected to an internal cannula (28 gauge; 14 mm long from the pedestal; C313I; Plastic One) with Intramedic polyethylene tubing (PE-50; inner diameter, 0.58 mm; outer diameter, 0.965 mm; Dow Corning, Midland, MI), was implanted subcutaneously in the interscapular region. The internal cannula was connected to the guide cannula, reaching the dorsoventral coordinate at -5.0 mm. The pumps (lot 10047-02; pumping rate, 0.29 μl/hr) were filled with vehicle solution (sterile saline), LPS (0.0718 μg/µl; yielding 0.5 μg/d), a mixture of LPS and MK-801 (LPS, 0.0718 μg/μl; MK-801, 0.1437 μg/μl; yielding 1 μg/d), or MK-801 (0.1437 μg/μl). The animals were killed 3 or 7 days after implantation of the mini-osmotic pumps. Brain preparation was performed as described above, except for the coronal sections that were cut at 30 μm thickness.
Surfactant-induced cell death
Intraparenchymal injections in mice were performed as described above, except that the right caudate putamen was reached, using the coordinates 0.0 mm anteroposterior, -2.0 mm lateral, and -3.0 mm dorsoventral. C3H/HeN and C3H/HeJ received 1 μl infusion of either Tween-20 solution (Sigma; filter sterilized at 0.02% concentration in phosphate saline buffer) or Tween combined to LPS (2.0 μg). In another set of experiments, CD1 mice received an i.p. injection of dexamethasone (DEX) sodium phosphate (10 mg/kg, Sabex, Boucherville, Qc, Canada) or vehicle 1 h before the intracerebral insults. The animals were killed 48 h after the intrastriatal infusion, and the tissues were processed as described.
cRNA Probes and in situ hybridization
Plasmids were linearized and the sense and antisense 35 S-labeled riboprobes were synthesized as described before [(34), refer to Table 1 for details]. The riboprobes for mouse proteolipid protein (PLP), myelin oligodendrocyte glycoprotein (MOG), and Olig1 were generated from pCRII-topo vectors (Invitrogen) containing amplification PCR products of a mouse brain cDNA library. The list of primers and size of the products are described in Table 2 . Mouse PDGFR-α riboprobe was generated from a pGEM3 vector (a generous gift from Dr. Chiayeng Wang, University of Illinois, Chicago, IL) and rat Olig1 and human Olig2 riboprobes were generated from pBluescript II and pRBRAH16 vectors, respectively (kindly provided by Dr. David H. Rowitch, ana-Farber Cancer Institute, Boston, MA). A pGEM7 vector was used to synthesize the CX3CL1 probe (Dr. Wilhelm J. Schwaeble, University of Leicester, UK). The plasmids were analyzed for sequence confirmation and orientation.
Hybridization histochemical localization of the different transcripts was performed on every 6th or 12th section of the entire rostrocaudal extent of each brain, as described previously (34) . The sections were exposed at 4°C to X-ray films (Biomax; Kodak, Rochester, NY) for 1-3 d. The slides were, thereafter, defatted in xylene, dipped into NTB-2 nuclear emulsion (diluted 1:1 with distilled water; Kodak), and exposed from 3 to 10 d depending on transcripts.
Histological analysis and DAPI staining
Myelin content and byproducts were determined via Sudan Black B staining (SBB). The brain sections mounted onto poly-L-lysine-coated slides were dehydrated through graded concentrations of alcohol (50 and 70%; 2 min each) and incubated for 1 h in SBB solution (Sigma, 0.3% saturated solution in 70% ethanol). The sections were then rinsed in 70% ethanol until the desired contrast was reached, washed in water and stained with DAPI solution [(0.0002% 4',6'-diamidino-2-phenylindole (Molecular Probes, Eugene, OR)] for 2 min, washed in water, and coverslipped with a polyvinyl alcohol (Sigma-Aldrich) mounting medium containing 2.5% 1,4-diazabicyclo(2,2,2)-octane (Sigma-Aldrich) in buffered glycerol (SigmaAldrich).
Photomicrographs were taken with the same exposure time using a digital camera (QIMAGING) mounted directly on a microscope (Nikon Eclipse 80i) equipped with a triple band DAPI/FITC/TRITC epifluorescence filter (Chroma Technologies; Rockingham, VT) and connected to a PC computer (Pentium 4; Dell Computers). Nissl stain (0.25% thionine solution) was used as a general index of cellular morphology and for measurements of lesion size.
Quantitative analysis
Semi-quantitative analyses of hybridization signals were performed as described previously (33, 35) . Quantification of area without signal (demyelinated regions and zones associated with lesions) was performed on X-ray films (Biomax) under a Northern Light Desktop Illuminator (Imaging Research) or a Bmax optical system (BX-50; Olympus) using a Sony Camera Video System attached to a Micro-Nikkor 55 mm-Vivitar extension tube set coupled to a computer and NIH Image J software version 1.23p (National Institutes of Health, Bethesda, MD). Area determination was conducted using X-ray film (PLP, MOG and fractalkine transcripts) or emulsion-dipped slides (PDGFR-α, Olig1 and Olig2) when better resolution was judged to be necessary.
The volumetric analysis was quantified using a C-80 Nikon microscope (Nikon, Montréal, QC) fitted to a Retiga EXi Fast digital camera (QImaging, Burnaby, BC) feeding to a Precision 660 workstation (Dell Computers, North York, ON). Systematically sampled sections (every 6th section covering the entire lesion surface) were stained with 0.25% thionin. Lesion volume was estimated by the Cavalieri method using Neurolucida Stereo Investigator software (Microbrightfield, Colchester, VT) driving a motorized stage (Ludl, Hawthorne, NY) on the microscope with a 4× plan apochromat objective. A 100 µm point grid was overlaid on a Wacom pen tablet (Wacom, Vancouver, WA) for each section and the points that fell within the damaged tissue were counted. Point counts were converted to volume estimates taking into account sampling frequency, magnification, grid size, and section thickness.
Comparison of group means was performed by means of a one-or two-way ANOVA followed by a Bonferroni procedure, as post hoc multiple comparisons test. Student's t test was used for comparisons between two independent groups after testing for homogeneity of variances. All the analyses were performed with SPSS software version 11.0.
RESULTS
LPS treatment induces PDGFR-α and modulates early events following acute demyelination
A single intracerebral LPS bolus was used to cause a rapid and transient innate immune reaction in microglia. We have then verified whether this acute response could alter OPCs, which can be identified by the expression of the gene-encoding platelet-derived growth factor receptor (PDGFR)-α (36). As expected, LPS injection at the level of corpus callosum activated microglia in the ipsilateral side of injection as depicted by the robust hybridization signal for TLR2 transcript (Fig. 1B) . TLR2 expression is a sensitive marker of microglial activation in a variety of models (37, 38) . Microglia activation was not associated with extensive demyelination, because only a localized loss of myelin staining was detected in the corpus callosum close to the site of injection (Fig. 1C ). In contrast, the level of microglia activation correlated with a widespread increase in PDGFR-α mRNA levels throughout brain parenchyma 2 days after injection (Fig. 1D, E) . This led us to further investigate OPC gene expression in an inflammatory context. Acute demyelination through administration of toxins like ethidium bromide (EtBr) has been used to study the mechanisms controlling myelin repair (29, 39-41). We then determined whether LPS could modify Olig1 and Olig2 gene expression following EtBr-mediated lesion. We observed that at 2 days post lesion, cells that strongly express Olig1 and Olig2 accumulate at the edge of the lesion. LPS co-infusion switched this pattern to a spread distribution of Olig1-and Olig2-positive cells (Fig. 2B ). To quantify these anatomical changes, a measure of differential O.D. in delimitated regions was performed. To define a value for the "edge effect", the O.D. taken from the border of the lesion ( Fig. 2A , region a) was subtracted from the O.D. of the adjacent area ( Fig. 2A, region b ). For the "spread effect," the O.D. from region "b" was subtracted from the O.D. of the corresponding area in the contra-lateral side (region c). The statistical analyses revealed a significant decrease of the "edge effect" in EtBr/LPS-treated samples compared with the EtBr group, while the "spread effect" was increased by LPS coinfusion (Fig. 2C) . Hence, accumulation of Olig1-and Olig2-positive OPCs at the border of the lesion is decreased by LPS, given that the differential O.D. is higher in the "edge effect" of EtBrtreated mice than in the "spread effect" of EtBr/LPS-challenged animals (P<0.05, for both transcripts). Microglia activation was not impaired by EtBr since TLR2 expression was even higher in the EtBr/LPS-infused mouse brains compared with those receiving EtBr or LPS alone (Supplemental Figs. 1 
and 2).
It is important to note that the endotoxin had by itself the ability to change the expression pattern of OPC mRNAs. Although Olig1-and Olig2-positive cells remained close to the injection site in saline-injected mice, these transcripts were no longer concentrated in this region following the single LPS treatment. Indeed, a "spread effect" similar to the one reported comparing EtBr Vs EtBr/LPS was observed in response to LPS administration (data not shown).
Brain immunity improves OPC mobilization to demyelinated sites
We next determined whether activation of immune response in the CNS by LPS improved or worsened tissue repair in terms of size of the region to be remyelinated. At 5 days post-lesion, EtBr administration caused severe demyelination in regions that no longer expressed transcripts for PDGFR-α, Olig1, Olig2, and myelin components such as proteolipid protein (PLP) and myelin oligodendrocyte glycoprotein (MOG) (Fig. 3) . Microglia activation by LPS, which persisted until 5 days post-injection (Supplemental Fig. 2 ), significantly reduced the size of the area non-populated with OPCs as assessed by PDGFR-α gene expression. In addition, LPS caused the same effect for Olig1-and Olig2-positive cells ( Fig. 3A and B) . PLP is a major constituent of myelin, and its reappearance was enhanced by the inflammatory treatment. MOG was analyzed at the mRNA level to corroborate the PLP results. As for PLP, LPS significantly attenuated the effects of EtBr on MOG-expressing regions (Fig. 3C, D) , implying that microglia activation does indeed lead to a better outcome. In addition, we found that LPS co-infusion result in less accumulation of myelin debris and byproducts that may delay brain recovery (Fig. 4) .
Innate immunity mediated-demyelination is permissive to OPC reactivity
We have described previously that MK-801, an antagonist of N-Methyl-D-Aspartate (NMDA) glutamate receptor subtype, exacerbated microglia response triggered by LPS in the brain of C3H/HeN mice, but not in C3H/HeJ TLR4-deficient animals. Moreover, continuous LPS/MK-801 infusion caused demyelination within 3 days (33). Using this model, we assessed the effects of innate immune response on OPC recruitment and reactivity in non-demyelinating (LPS alone) and demyelinating (LPS/MK-801) region showing inflammation. The use of PDGFR-α mRNA as a marker of OPCs indicated a very active mobilization of these progenitors in this context. Both LPS/MK-801 and LPS treatments increased PDGFR-α transcript levels at 3 and 7 days of treatment, meaning that OPC recruitment is actually stimulated by innate immunity independently on the loss in myelin content ( Fig. 5A and B) .
Loss in PLP gene expression levels is observed following acute demyelination but surprisingly, we were not able to find sensitive decrease in PLP mRNA levels in the selected time-course. A localized induction was instead detected, especially at 7 days of treatment combining LPS and MK-801, but not in samples treated with saline, LPS, or MK-801 alone ( Fig. 5C and D) . Interestingly, Olig1 mRNA levels were increased only in the brain of LPS/MK-801-treated animals ( Fig. 5E and F) . Such association with demyelination was not as direct as for Olig2, which is also linked to gene transcription in OPCs responding to demyelination (42) . Olig2 transcript showed a complex pattern of expression over the time. At time 3 days, Olig2 mRNA was only induced by LPS/MK-801 infusion, while at 7 days both double treatment and LPS alone were as effective to up-regulate this transcription factor ( Fig. 5G and H) .
Inflammation increases tissue resistance against surfactant-mediated cell lysis
The experiments with acute and chronic models of demyelination clearly show that innate immunity triggers recruitment of OPCs and accelerates the remyelination process. We next wanted to determine whether such a beneficial effect of inflammation was specific to the mechanisms involved in myelin repair or if it is a more general feature of neuroprotection. As depicted by the Fig. 6 , the detergent Tween-20 provoked a localized damage when infused into the cerebral tissue (Fig. 6A) . Surprisingly, co-administration of LPS essentially abolished the neurotoxic properties of the cell lysis agent. To discard the possibility that LPS was neutralizing the surfactant via chemical interactions, we used C3H/HeJ mice that bear a loss of function in the toll-like receptor (TLR) 4 gene and are non-responsive to LPS. While the endotoxin decreased the necrotic area in the control C3H/HeN mice at time 2 days post injection, no difference was found in the brain of the mutant C3H/HeJ mice ( Fig. 6A and B) . Interaction of LPS with its cognate TLR4 and activation of proinflammatory signaling in microglia is the neuroprotective mechanism against Tween-20.
Dexamethasone (DEX) is a potent antiinflammatory drug that effectively prevents NF-κB activation in the brain (43) . DEX is an analog of glucocorticoids and such class of steroids strongly inhibits inflammatory signaling and gene expression in microglia (35, 44) . In this case, Tween-20 was highly toxic to the cerebral tissue when the inflammatory response was inhibited by DEX ( Fig. 6C and D) . This confirms the protective role of innate immunity in this acute model of brain injury. Finally, we analyzed the expression of CX3CL1 (fractalkine), which is a chemokine ubiquitously expressed in neurons and mediates cellular communication with microglia (45) . As for the Nissl-stained sections, DEX significantly increased the area that failed to show CX3CL1 hybridization signal 2 days after the localized administration of the cell lysis agent (Fig. 6E and F) . These data, together with the decrease in CX3CL1 mRNA in injured neurons (45) , provide clear evidence that innate immunity and proinflammatory signaling in microglia play a critical role to protect neurons in presence of highly toxic compounds.
DISCUSSION
Brain innate immune response and OPC reactivity
Activation of brain innate immune response by LPS has a direct impact on OPC reactivity, as judged by an increase in PDGFR-α expression. To discard that the alteration in OPC activity was a consequence of demyelination, we performed Sudam Black B staining for evaluation of myelin content. Since only restricted demyelination was observed following LPS infusion and PDGFR-α induction correlated with microglia activation, we assume that the ability of LPS to induce PDGFR-α is probably a property of some proliferating cells, such as fibroblasts (46) , rather than being a consequence of a localized demyelination. However, these effects of LPS administration may be indirect, because microglia seem to be the only type of cells in the CNS that express TLR4 (47). We cannot rule out the possibility that OPCs express low copies of that receptor and thus be a direct target, because the endotoxin can activate these progenitors without causing demyelination. A direct interaction of LPS with its cognate TLR4 in microglia and then production of proinflammatory cytokines (e.g., TNF-α) is likely to be the mechanism leading the OPC mobilization. Activation of TNF receptor type 2 plays a critical role for the recruitment of OPCs and remyelination in acute models of demyelination (48).
In addition of being a marker of OPCs, PDGFR-α is the signal transducer that inhibits the premature differentiation of progenitors into oligodendrocytes and promotes OPC proliferation and motility (49, 50). Thus, LPS may prime OPCs to mobilize in a more efficient manner during remylination process. This was further investigated by analyzing the pattern of Olig1 and Olig2 gene expression following EtBr-induced demyelination. Indeed, the anatomical distribution of Olig1-and Olig2-positive cells at the border of the lesion was dramatically changed by LPS coinfusion. While these cells tend to accumulate at the edge of the demyelinated sites spontaneously, inflammatory treatment was able to switch the pattern to a spread-like distribution. Even though we did not determine whether Olig1-and Olig2-positive cells differentially migrated toward the lesion site or whether these cells were there before and then migrated away from the lesion, the net effect is that inflammation switched the pattern of Oligexpressing cells in the injured tissue. The meaning of these transient changes in the anatomical distribution of Olig1/2-positive cells is not known. There is evidence that accumulation of OPCs and myelin-producing cells around the lesion may contribute to the formation of tissue scar, which impairs axon growth and proper tissue recovery (51-53). In this way, microglia activation by LPS may improve brain repair by avoiding concentration of inhibitory molecules at the border of the injured site. It is also not known by which mechanism microglia activation could affect the pattern of Olig1/2-positive cells. Nevertheless, this process could be related to the fact that OPC recruitment is modulated by CXCL1 chemokine, which is associated with inflammation and has the ability to halt OPC migration (54). It has been suggested that recruitment of remyelinating cells is restricted due to a narrow rim of normal tissue surrounding an area of demyelination, what could be improved by preventing the premature differentiation and increasing the level of recruitment signal (55). It is likely that components of the innate immunity may facilitate remyelination. LPS treatment avoids precipitated accumulation of progenitors in differentiation process at the border of the lesion, opposing to what would make difficult for OPCs to migrate and mature into oligodendrocytes far within the core of the lesion.
LPS treatment enhances OPC recruitment to demyelinated sites
In addition to modulating early events related to OPC behavior, stimulation of the CNS innate immune system modifies the outcome of recruitment of cells involved in remyelination process. We observed a reduction in the size of the area non-populated with OPCs 5 days post-lesion when LPS was combined to EtBr. At this time-point accumulated or spread distribution of Olig1 and Olig2-positive cells relative to the lesion site was no longer present. The reduction in the area negative for PDGFR-α mRNA was associated with similar events regarding Olig1, Olig2, PLP and MOG transcripts. PLP is a major constituent of myelin and loss in PLP mRNA levels is observed following acute demyelination (40) . The ability of LPS to enhance reappearance of PLP gene expression indirectly suggests an improved tissue repair, because mice lacking PLP develop widespread axonal swellings and degeneration (56). Although our PLP probe may also recognizes DM20, which is expressed in non-differentiated oligodendrocyte progenitors (14) , it has been shown that PLP/DM20 probe detects transcript signals reappearing after EtBr lesions in a manner that correlated with the distribution of new myelin sheaths (40) . MOG analyzed at the mRNA level confirmed PLP observations. Inflammation may then rescue more tissue by mobilizing cells instead of protecting the tissue from the injury, because LPS did not modify the size of areas non-populated with OPCs at time 2 days post-insult (data not shown). In addition, activation of innate immunity plays an important role in cleaning myelin debris rendering the tissue prone to be repopulated with new myelinating cells, since delayed remyelination after EtBr lesion is associated with areas where myelin debris removal is inefficient (39) . The role of myelin removal remains nevertheless controversial, because it has been shown that macrophages can affect OPCs independently on myelin debris clearance (57).
Altogether, we propose that stimulation of brain innate immune response improves OPC mobilization to repair tissues from an acute injury at more distal sites into the core of the lesion. These data may counterbalance a proposed unfavorable role of brain inflammation in demyelinating diseases. The correlation between inflammation and demyelination process observed by many groups (58) advocates for the use of anti-inflammatory treatment to prevent greater myelin damage. Also, LPS injection in immature rodents seems to result in oligodendrocyte loss and hypomyelination (47). Although inflammation triggered by LPS in the spinal cord seems to cause demyelination (59) , it has been shown that molecules associated with immune response, such as TNF-α, IL-1β, and LIF enhance remyelination (48, 60, 61). Recently, Foote and Blakemore (62) stimulated remyelination in non-remyelinating OPC-populated areas by using sterile charcoal to induce acute inflammation. We now report that LPS-induced microglia activation leads to a more efficient OPC recruitment, enhances expression of key transcription factors linked to remyelination and prevents accumulation of myelin byproducts.
OPC recruitment and gene expression in the course of innate immunity-mediated demyelination
The model of LPS/MK-801 long-term infusion provided important information by dissociating inflammatory effects on OPC reactivity and gene expression in demyelinating and nondemyelinating contexts. Our results show that PDGFR-α is induced by LPS at levels comparable with those induced by LPS/MK-801 treatment. This observation, combined with that described using acute inflammation, clearly shows an effect of LPS on OPC independently of demyelination. Although it has been demonstrated recently that LPS increases OPCs number in vitro, to our knowledge this is the first demonstration of such an effect in both acute and chronic in vivo models without requirement of myelin loss. In addition, we report the surprising increase in PLP mRNA levels in demyelinated brains treated with LPS/MK-801. Importantly, Olig1 transcript expression was strongly coupled with PLP gene expression, showing that two genes associated with remyelination are induced specifically by the demyelinating inflammatory treatment. Such correlation was not as evident for Olig2 transcript, which showed a complex pattern of temporal expression between treatments. This observation is not totally unexpected, because Olig2 expression is involved in oligodendrocyte lineage specification and it may not be
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as critical as Olig1 for remyelination (23, 25, 29, 30). Thus, its irregular behavior could also be associated with PDGFR-α pattern of induction. The complex pattern of PLP and Olig1/2 gene expression may rely on two possibilities: a) in this model there is a decrease in the myelin content but there is no cell death of myelin-producing cells, making possible for these cells to start immediately their transcriptional programs involved in myelin repair; b) oligodendrocyte cell death is indeed taking place, but due to the inflammatory nature of the treatment, cells were replaced rapidly and expressed the aforementioned genes at different times.
Our results suggest that ongoing innate immune activity stimulates OPC response and is permissive to the expression of transcripts associated with myelin repair, such as Olig1 and PLP, at the lesion site. These data are in agreement with those showing proliferation and mobilization of progenitor cells in response to inflammation using experimental allergic encephalomyelitis (EAE), a model of MS (63, 64) . However, our results show that OPC mobilization happens in the course of sole innate immune response, while EAE model is dependent on adaptive T cell responses (65) .
TLR4-mediated neuroprotection in a model of cell lysis injury
To verify whether an improved outcome through stimulation of microglial cells is restricted to myelin repair or if it is a broader event, experiments were conducted to assess brain damage when LPS is combined to a toxic surfactant compound. We provide strong evidence that microglia activation confers neuroprotection against tween-20 in a TLR4-dependent manner. Such observation was further supported by the fact that DEX increased the damage caused by the detergent. Although surfactant cell lysis may not reproduce a specific pathological condition, many molecules involved in diseases have cytolytic properties, such as perforin produced by lymphocytes, the complement system and bacterial toxins including pneumolysin during Streptococcus pneumoniae meningitis (66, 67) . Lysophosphatidylcholine, which is a metabolic product of phospholipase A 2 used to induce demyelination, has detergent-like properties (68) , implying that surfactant lesion model may elucidate important mechanisms involved CNS diseases. Cellular mechanisms of cell resistance, like those involving heat-shock protein 90, may also protect cells equally from detergents, complement attack, and hypoxia-mediated lysis (69) . Therefore, activation of TLR4 and NF-κB may be neuroprotective by either increasing cell resistance or by removing toxic molecules via an increased phagocytic capacity of activated microglia.
LPS was found to promote injury specifically in the substantia nigra (70), whereas endotoxin exposure increased susceptibility to ischemic injury (71) . In our previous studies we found cerebral damages only when LPS was administered with RU486, which severely alters feedback mechanisms on immune cells (35, 72) . Although it has been shown that individual components of the immune response enhance recovery or confer neuroprotection (12, 13, 73) , here we show that innate immunity and TLR4 signaling in microglia protects neurons in presence of toxic agents and triggers transcriptional activation of genes involved in OPC recruitment and myelin repair. The net functional consequences of these data have yet to be determined. The present series of experiments was designed to analyze acute changes of OPC reactivity to LPS in association with demyelinating processes and more severe CNS insults. Moreover, the anatomical regions were chosen on the basis of myelin fibers (corpus callosum), easy access and reproducibility of the damage (dorsal basal ganglia). Using these coordinates we could not detect obvious behavioral changes following the different treatments, which could have been used to evaluate functional recovery. It will be of interest to combine various approaches (behavior, electrophysiological, ...) and other target regions to provide such net functional effects of TLR4 signaling and OPCs in brain repair and neuroprotection.
The results presented in this study point toward a powerful neuroprotective role for innate immunity on brain reactivity to injury. This is supported by the acute effect of LPS, which increases PDGFR-α transcript levels, prevents accumulation of myelin debris, avoids premature accumulation of Olig1/2-positive cells restricted to the border of EtBr lesions, and reduces the size of the concomitant area negative in cells expressing genes involved in OPC recruitment, differentiation, and remyelination. In the course of an ongoing innate immune response, cells expressing Olig1, Olig2, and PLP are normally recruited to the demyelinated sites, whereas OPC PDGFR-α gene expression was increased by LPS independently of demyelination. Accordingly, LPS-induced microglia activation renders the brain tissue more responsive to myelin repair. This beneficial effect is broadened to a more aggressive model of injury, in which LPS through TLR4 and NF-κB signaling reduced surfactant-mediated damage while antiinflammatory treatment by DEX enlarged the lesion. Representative examples of nuclear emulsion dipped coronal sections depicting no signal (delimited by dashed white lines) for genes involved in oligodendrocyte progenitor cell (OPC) recruitment and differentiation: PDGFR-α, Olig1, and Olig2 as indicated in the figure. B) The brain surface without hybridization signal was measured and pooled across each 12th section from the beginning to the end of the lesion for each sample. C, D) The demyelinated regions [area with no signal for the gene encoding myelin components, proteolipid protein (PLP) and myelin oligodendrocyte glycoprotein (MOG)] are also smaller in mice that received EtBr together with LPS compared to EtBr-challenged animals. The demyelinated area was measured and pooled across each 6th section from the beginning to the end of the lesion for each sample. Results represent means ± SEM of 3 to 5 mice per group. Statistical analysis was performed by using a one-way analysis of variance (ANOVA) followed by a Bonferroni's multiple comparison test. Significantly different (***P<0.001) from the saline-injected group; significantly different (##P<0.005, ###P<0.001) from the EtBr-treated group. 
